EP3565592
Meðhöndlun á efnaskiptasjúkdómum með því að hindra mýóstatín-virkni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.1.2018EP published:
1.3.2023EP application number:
18701237.2
EP translation filed:
24.4.2023Grant published:
15.5.2023EPO information:
European Patent Register
Max expiry date:
4.1.2038Expiry date:
4.1.2027Next due date:
31.1.2027
Title in English:
TREATING METABOLIC DISEASES BY INHIBITING MYOSTATIN ACTIVATIONLanguage of the patent:
English
Timeline
Today
5.1.2018EP application
1.3.2023EP Publication
24.4.2023Translation submitted
15.5.2023Registration published
4.1.2027Expires
Owner
Name:
Scholar Rock, Inc.Address:
301 Binney Street, 3rd Floor, Cambridge, MA 02142, US
Inventor
Name:
DONOVAN, AdrianaAddress:
West Roxbury MA 02132, US
Name:
STRAUB, MichelleAddress:
Yarmouth ME 04096, US
Name:
WAWERSIK, StefanAddress:
Westborough MA 01581, US
Name:
CHYUNG, YungAddress:
Lexington MA 02421, US
Name:
WEBSTER, MicahAddress:
Nashua NH 03063, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762443455 PDate:
6.1.2017Country:
US
Number:
17150586Date:
6.1.2017Country:
EP
Number:
201762530311 PDate:
10.7.2017Country:
US
Number:
201762608069 PDate:
20.12.2017Country:
US
Classification
Categories:
A61K 39/395, C07K 16/22, A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/08, A61P 3/10, A61P 5/50, A61P 9/00, A61P 9/10, A61P 21/00, A61P 21/06, A61P 25/00, A61K 39/00, A61P 19/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 30.1.2024
Expires: 4.1.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 13.1.2025
Expires: 4.1.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 12.1.2026
Expires: 4.1.2027
Payer: G.H. Sigurgeirsson ehf.